Literature DB >> 9453927

[Insulin-dependent diabetes and psychiatric pathology: general clinical and epidemiologic review].

R Eiber1, I Berlin, A Grimaldi, J C Bisserbe.   

Abstract

Insulin dependent diabetes mellitus is one of the most common metabolic diseases and affects 150,000 persons in France. To achieve good metabolic control requires a strict daily management of the treatment by the patients themselves. Lack of active involvement can have direct consequences which underlines the importance of a good adherence to the treatment. About 50% of the patients do not obtain adequate metabolic control. The major problem of insulin treatment consists in the repeated occurrence of severe hypoglycemias which may be accompanied by an alteration of the perception of hypoglycaemic signs. On the other hand, when the risk of severe hypoglycaemia is removed, glycosylated haemoglobin levels rise. Permanent hyperglycaemia leads to numerous somatical complications. An extremely dramatic combination of these two types of metabolic unbalance is represented by the brittle diabetes characterised by very frequent and extreme oscillations between hypo and hyperglycaemia. This raises the question of the influence of psychopathological factors on metabolic control and the possibility of improving metabolic control by acting on these factors. Epidemiological studies in diabetic patients have established higher prevalence rates of psychiatric disorders, in particular mood and anxiety disorders. The current prevalence rate of depression was found to be homogeneous in the literature about 11% and life time prevalence rates of major depressive disorders vary between 24% and 29%. The symptom profile of depression in diabetic patients is similar to that in depressed non diabetic psychiatric patients and it has been shown that highly sensitive psychiatric diagnosis of depression can be made among diabetic patients. There is no specific personality pattern in diabetic patients. There seems to be a relationship between metabolic control as defined by glycosylated haemoglobin and psychiatric disorders. Indeed, high levels of glycosylated haemoglobin are found in patients with psychiatric disorders. There seems to be some evidence of an association between blood glucose levels and actual emotional states. Nothing is known about the specificity of the link between psychiatric disorders and insulin-dependent diabetes mellitus. No study has evaluated if the relationship between psychiatric disorders and insulin-dependent diabetes mellitus is due to the disease itself or to the chronic feature of diabetes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453927

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  4 in total

Review 1.  A review of treating depression in diabetes: emerging findings.

Authors:  Sarah M Markowitz; Jeffrey S Gonzalez; Jesse L Wilkinson; Steven A Safren
Journal:  Psychosomatics       Date:  2011 Jan-Feb       Impact factor: 2.386

2.  Association between emotional and behavioral problems and metabolic control in children and adolescents with Type 1 diabetes.

Authors:  S Akbaş; K Karabekiroğlu; T Ozgen; G Tasdemir; M Karakurt; A Senses; O Böke; M Aydin
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

3.  Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial.

Authors:  Ruiying Kang; Yan He; Yuxiang Yan; Zhiwu Li; Yeqing Wu; Xiaojuan Guo; Zhigang Liang; Jun Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-27       Impact factor: 2.570

4.  Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial.

Authors:  Tingting Che; Xiaochun Teng; Qun Huang; Yanfei Mu; Xianjun Tang; Xiaosong Mu; Youneng Wei
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-13       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.